Vassiliki Papastavros

Vassiliki Papastavros practices at Dermatology Group of Florida, P.A. in South Miami, Florida.

Vassiliki Papastavros' NPI, 1689038549, was assigned on April 7, 2016. Vassiliki Papastavros graduated from University Of Florida College Of Medicine in 2016. Vassiliki Papastavros holds Florida license ME148876.

Vassiliki Papastavros' primary practice is Dermatology Group of Florida, P.A., at 7800 Sw 57th Ave, South Miami, FL 33143 in Miami-Dade County. The practice phone is (954) 807-9332.

Vassiliki Papastavros' primary practice is Dermatology Group of Florida, P.A. in South Miami, Florida. The medical group on file is Dermatology Group of Florida. Dmand AI also links Vassiliki Papastavros to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Vassiliki Papastavros practices. Vendor and product names are available with a free account.

Dermatology is Vassiliki Papastavros' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Vassiliki Papastavros is board certified in dermatology by the American Board of Dermatology. Dmand AI has Vassiliki Papastavros' licenses on file in 2 states: Florida and District of Columbia.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes and psoriasis among the conditions Vassiliki Papastavros treats.

CMS data shows 620 Medicare services from Vassiliki Papastavros across 11 procedure codes in 2024, for 207 Medicare patients. Medicare paid $31,268 for them. Every service was in an office.

CMS counts 207 Medicare patients who saw Vassiliki Papastavros in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Vassiliki Papastavros' median patient age at 52, with 65% women.

In 2024, Vassiliki Papastavros wrote 1,006 Medicare Part D claims for 355 patients. 89% of them were for generic drugs. CMS names the drug for 880 of them, across 18 drugs with 11 or more claims each, at $299,549 in total drug cost. In 2023, CMS named 850 claims across 17 drugs.

Vassiliki Papastavros accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 143 procedures of removal of skin lesions by Vassiliki Papastavros, more than 77% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Vassiliki Papastavros, published from 2016 to 2020. Vassiliki Papastavros' most frequent co-authors are Tania Marie Gonzalez Santiago, MD, Mary Piazza Maiberger, MD and Rajiv Kiran Nathoo, MD.

CMS Open Payments shows 500 general payments to Vassiliki Papastavros from 31 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 97% of the total. Sanofi and Genzyme US Companies paid the most, $1,277.

Dmand AI lists 1 award for Vassiliki Papastavros.

Vassiliki Papastavros graduated from University Of Florida College Of Medicine in 2016. Vassiliki Papastavros is a member of AAD and ASDS.

Vassiliki Papastavros is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.